<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03806712</url>
  </required_header>
  <id_info>
    <org_study_id>P/2019/413</org_study_id>
    <nct_id>NCT03806712</nct_id>
  </id_info>
  <brief_title>Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)</brief_title>
  <acronym>R-PLQ</acronym>
  <official_title>Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Limited data is available for end of life care in hematologic malignancies, moreover with
      thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow
      involvement in those diseases or its treatments. Yet, a few studies was interested in,
      whereas platelet transfusion is the only treatment indicated. As it represent a scarce,
      limited resource, the ethical principles are in conflict in this setting and there's a lack
      of recommendation. The final decision is take by the clinician and his patient, but no study
      exist in representation of the two parts. We provide a qualitative study to understand what
      this decision is made of.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">July 22, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measure the impact of social representation on platelet transfusion practice</measure>
    <time_frame>3 months</time_frame>
    <description>inner core and peripheral items of platelet transfusion of each participant will be collected until reaching saturation, it's to say that the repetition of some terms will be measured between each interview thank's to a questionnaire of at least two principals opened questions.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">45</enrollment>
  <condition>Platelet Transfusion</condition>
  <condition>Hematological Malignancy</condition>
  <condition>Palliative Care</condition>
  <arm_group>
    <arm_group_label>patient</arm_group_label>
    <description>patient with advanced, non curative hematological malignancies multi method questionary, at least 1 hour per patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>hematologist</arm_group_label>
    <description>medical practitioner of platelet transfusion multi method questionary, at least 1 hour per hematologist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nurses</arm_group_label>
    <description>nurses working in hematology, practicing platelet transfusion multi method questionary, at least 1 hour per nurse</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>multi method questionary (developped by De Rosa, in 1995 and 2014)</intervention_name>
    <description>questions from an association network according to the subject and the grounded theorise (Glasser and Strauss)</description>
    <arm_group_label>Nurses</arm_group_label>
    <arm_group_label>hematologist</arm_group_label>
    <arm_group_label>patient</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with advanced hematological malignancies, transfused in platelet regulary,
        hematologist's nurses who practice platelet transfusion and hematologist who prescribe the
        transfusion.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  major patient

          -  patient with advanced hematological malignancies

          -  patient transfused in platelet regularly (3 time at least in last month)

          -  medical practioner, hematologist, prescribing platelet transfusion at least one per
             week.

          -  nurse working in hematology, practicing platelet transfusion at lest one peer week.

        Exclusion Criteria:

          -  minor patient

          -  non communicant patient

          -  non transfused platelet patient

          -  non voluntary patient or hematologist or nurses

          -  non graduated hematologist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Moracchini</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.psychologie-sociale.com/index.php/fr/theories/normes/18-des-attributions-causales-aux-imputations-de-responsabilite</url>
    <description>social representation course</description>
  </link>
  <reference>
    <citation>McGrath P, Leahy M. Catastrophic bleeds during end-of-life care in haematology: controversies from Australian research. Support Care Cancer. 2009 May;17(5):527-37. doi: 10.1007/s00520-008-0506-1. Epub 2008 Sep 23.</citation>
    <PMID>18810505</PMID>
  </reference>
  <reference>
    <citation>McGrath P, Holewa H. Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care (Engl). 2007 Mar;16(2):164-71.</citation>
    <PMID>17371426</PMID>
  </reference>
  <reference>
    <citation>Jeoffrion C, Dupont P, Tripodi D, Roland-Lévy C. [Social representations of illness: Comparison of &quot;expert&quot; knowledge and &quot;naïve&quot; knowledge]. Encephale. 2016 Jun;42(3):226-33. doi: 10.1016/j.encep.2015.12.007. Epub 2016 Jan 12. French.</citation>
    <PMID>26796561</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>December 30, 2018</study_first_submitted>
  <study_first_submitted_qc>January 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2019</study_first_posted>
  <last_update_submitted>July 24, 2019</last_update_submitted>
  <last_update_submitted_qc>July 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>social representation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematologic Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>interview will be registered then transcribe on professional computer ans accessible only by the investigator and collaborators.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

